Print

Merck V520-007

Safety and Immunogenicity of a three-dose homologous regimen of Ad5 and MRKAd5 HIV-1 gag vaccines

Trial Details:

I Completed
Merck
Ad-5 HIV-1 gag (Merck),MRKAd5 HIV-1 gag Ad5 Gag B; Ad5 Gag B
Ad-5 HIV-1 gag (Merck) Viral Vector - Adeno
MRKAd5 HIV-1 gag Viral Vector - Adeno
USA 252